NASDAQ:INGN Inogen (INGN) Stock Price, News & Analysis $9.67 -0.03 (-0.31%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$9.46▼$9.9250-Day Range$7.27▼$9.7552-Week Range$4.13▼$10.64Volume140,068 shsAverage Volume160,119 shsMarket Capitalization$228.02 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Inogen alerts: Email Address Inogen MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside27.6% Downside$7.00 Price TargetShort InterestBearish6.23% of Shares Sold ShortDividend StrengthN/ASustainability-1.12Upright™ Environmental ScoreNews Sentiment0.45Based on 7 Articles This WeekInsider TradingSelling Shares$85,600 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.20) to ($1.94) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.09 out of 5 starsMedical Sector618th out of 936 stocksSurgical Appliances & Supplies Industry15th out of 18 stocks 1.0 Analyst's Opinion Consensus RatingInogen has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageInogen has only been the subject of 2 research reports in the past 90 days.Read more about Inogen's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted6.23% of the outstanding shares of Inogen have been sold short.Short Interest Ratio / Days to CoverInogen has a short interest ratio ("days to cover") of 7.Change versus previous monthShort interest in Inogen has recently increased by 0.68%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldInogen does not currently pay a dividend.Dividend GrowthInogen does not have a long track record of dividend growth. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInogen has received a 51.98% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Medical ventilators" product. See details.Environmental SustainabilityThe Environmental Impact score for Inogen is -1.12. Previous Next 3.0 News and Social Media Coverage News SentimentInogen has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Inogen this week, compared to 2 articles on an average week.Search Interest2 people have searched for INGN on MarketBeat in the last 30 days. MarketBeat Follows4 people have added Inogen to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inogen insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $85,600.00 in company stock.Percentage Held by InsidersOnly 0.99% of the stock of Inogen is held by insiders.Percentage Held by Institutions89.94% of the stock of Inogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inogen's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Inogen are expected to grow in the coming year, from ($2.20) to ($1.94) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inogen is -2.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inogen is -2.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInogen has a P/B Ratio of 1.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Inogen's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. About Inogen Stock (NASDAQ:INGN)Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.Read More INGN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INGN Stock News HeadlinesJuly 27 at 1:22 AM | americanbankingnews.comInogen (NASDAQ:INGN) Raised to "Hold" at StockNews.comJuly 22, 2024 | investorplace.com3 Stocks Under $10 With the Potential for Massive GainsJuly 27, 2024 | Crypto 101 Media (Ad)Next opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…July 22, 2024 | investorplace.com3 Stocks Under $10 With the Potential for Massive GainsJuly 21, 2024 | seekingalpha.comOfferpad Solutions: Now Is The Time To Go Against The CrowdJuly 21, 2024 | americanbankingnews.comInogen (NASDAQ:INGN) Lowered to Sell at StockNews.comJuly 3, 2024 | businesswire.comInogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business DevelopmentMay 9, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Hold Rating on Inogen (INGN)July 27, 2024 | Crypto 101 Media (Ad)Next opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…May 9, 2024 | finance.yahoo.comEarnings Update: Here's Why Analysts Just Lifted Their Inogen, Inc. (NASDAQ:INGN) Price Target To US$7.00May 8, 2024 | finance.yahoo.comInogen, Inc. (NASDAQ:INGN) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comQ1 2024 Inogen Inc Earnings CallMay 8, 2024 | finance.yahoo.comInogen Inc (INGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Dynamics with ...May 7, 2024 | investorplace.comINGN Stock Earnings: Inogen Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | washingtonpost.comInogen: Q1 Earnings SnapshotMay 7, 2024 | finance.yahoo.comInogen Inc (INGN) Q1 2024 Earnings: Navigating Challenges with a Focus on GrowthMay 7, 2024 | businesswire.comInogen Announces First Quarter 2024 Financial ResultsApril 13, 2024 | seekingalpha.comInogen: New Management And A Major Competitor Exit Offer Some New OpportunitiesSee More Headlines Receive INGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today7/26/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:INGN CUSIPN/A CIK1294133 Webwww.inogen.com Phone(805) 562-0500FaxN/AEmployees834Year Founded2001Price Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside-27.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($4.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-102,450,000.00 Net Margins-30.07% Pretax Margin-30.14% Return on Equity-42.87% Return on Assets-28.44% Debt Debt-to-Equity RatioN/A Current Ratio2.70 Quick Ratio2.36 Sales & Book Value Annual Sales$315.66 million Price / Sales0.72 Cash FlowN/A Price / Cash FlowN/A Book Value$8.79 per share Price / Book1.10Miscellaneous Outstanding Shares23,580,000Free Float23,344,000Market Cap$228.02 million OptionableOptionable Beta1.07 Social Links The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Kevin R. M. Smith (Age 53)President, CEO & Director Comp: $1.62MMr. Jason Somer (Age 56)Executive VP, General Counsel & Corporate Secretary Comp: $401.03kDr. Stanislav Glezer M.D. (Age 51)MBA, Executive VP of R&D and Chief Medical Officer Comp: $575.36kMr. Michael J. Bourque (Age 61)Executive VP, CFO & Treasurer Mr. Philip CorrinSenior Vice President of Operations & Supply ChainMs. Jennifer Yi BoyerExecutive VP & Chief Human Resources OfficerMr. Vijay PaliwalSenior Vice President of Enterprise EnablementMr. Grgoire Ramade (Age 54)Executive VP & Chief Commercial Officer More ExecutivesKey CompetitorsInvacareNYSE:IVCJin Medical InternationalNASDAQ:ZJYLSanara MedTechNASDAQ:SMTILakeland IndustriesNASDAQ:LAKENutribandNASDAQ:NTRBView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 7,240 shares on 7/26/2024Ownership: 0.412%Assenagon Asset Management S.A.Sold 28,510 shares on 7/18/2024Ownership: 1.084%CWM LLCBought 6,339 shares on 7/10/2024Ownership: 0.028%Stokes Family Office LLCBought 70,500 shares on 7/5/2024Ownership: 0.483%Jacobs Levy Equity Management Inc.Sold 91,287 shares on 5/16/2024Ownership: 1.579%View All Insider TransactionsView All Institutional Transactions INGN Stock Analysis - Frequently Asked Questions How have INGN shares performed this year? Inogen's stock was trading at $5.49 on January 1st, 2024. Since then, INGN stock has increased by 76.1% and is now trading at $9.67. View the best growth stocks for 2024 here. How were Inogen's earnings last quarter? Inogen, Inc. (NASDAQ:INGN) announced its quarterly earnings data on Tuesday, May, 7th. The medical technology company reported ($0.62) EPS for the quarter, beating analysts' consensus estimates of ($0.76) by $0.14. The firm's revenue was up 8.1% compared to the same quarter last year. What is Scott Wilkinson's approval rating as Inogen's CEO? 70 employees have rated Inogen Chief Executive Officer Scott Wilkinson on Glassdoor.com. Scott Wilkinson has an approval rating of 46% among the company's employees. This puts Scott Wilkinson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Who are Inogen's major shareholders? Inogen's top institutional shareholders include Assenagon Asset Management S.A. (1.08%), Stokes Family Office LLC (0.48%), Bank of New York Mellon Corp (0.41%) and CWM LLC (0.03%). Insiders that own company stock include Alison Bauerlein, Jason Somer, Ray Benjamin M Anderson, Raymond Huggenberger and Brenton Taylor. View institutional ownership trends. How do I buy shares of Inogen? Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Inogen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), (MDVN) (MDVN), NVIDIA (NVDA), Alibaba Group (BABA) and Advanced Micro Devices (AMD). This page (NASDAQ:INGN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
